Markets · 1 sources covering this

Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market

The Danish company Novo Nordisk says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

MarketWatchCenter·2h ago
Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market
The Danish company Novo Nordisk says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
Read at MarketWatch →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/56f2aec7c6f92120ab711c372071323afda6f1e6"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Novo Nordisk&#x2019;s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market"></iframe>

Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market

How 1 sources are covering this

Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market

More from Markets

Here’s how to time your retirement to keep your healthcare costs down

An oil lifeline is under threat, and markets have yet to price in the growing crisis

SpaceX’s stock looks to snap brutal losing streak as it heads for one of its best days yet

Microsoft has 3 secret weapons that could drive its stock 50% higher, analyst says

Reader

Trust & legal

Across the network

How 1 sources are covering this

Novo Nordisk&#x2019;s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market

More from Markets

Here&#x2019;s how to time your retirement to keep your healthcare costs down

An oil lifeline is under threat, and markets have yet to price in the growing crisis

SpaceX&#x2019;s stock looks to snap brutal losing streak as it heads for one of its best days yet

Microsoft has 3 secret weapons that could drive its stock 50% higher, analyst says

Reader

Trust & legal

Across the network

Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market

Here’s how to time your retirement to keep your healthcare costs down

SpaceX’s stock looks to snap brutal losing streak as it heads for one of its best days yet